Boston Scientific To Acquire Axonics For About $3.7 Billion
January 08 2024 - 7:41AM
Dow Jones News
By Ben Glickman
Boston Scientific will acquire Axonics for about $3.7 billion in
cash.
The companies said on Monday that Axonics had agreed to be
bought for $71 a share. Boston Scientific said the deal gave
Axonics an equity value of $3.7 billion and an enterprise value of
$3.4 billion.
Axonics is developing medical technology focused on treating
urinary and bowel issues.
Boston Scientific said the deal would add technologies to its
portfolio to further serve urologists.
The deal is expected to close in the first half of 2024, subject
to the approval of Axonics stockholders and the receipt of
regulatory approvals.
Axonics will become a wholly-owned subsidiary of Boston
Scientific.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
January 08, 2024 07:26 ET (12:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Jan 2024 to Jan 2025
